Global Liposomes Drug Delivery Market Research Report 2020

Global Liposomes Drug Delivery Market Research Report 2020

Table of Contents
1 Liposomes Drug Delivery Market Overview
1.1 Product Overview and Scope of Liposomes Drug Delivery
1.2 Liposomes Drug Delivery Segment by Type
1.2.1 Global Liposomes Drug Delivery Sales Growth Rate Comparison by Type (2021-2026)
1.2.2 Liposomal Doxorubicin
1.2.3 Liposomal Amphoteracin B
1.2.4 Liposomal Paclitaxel
1.2.5 Others
1.3 Liposomes Drug Delivery Segment by Application
1.3.1 Liposomes Drug Delivery Sales Comparison by Application: 2020 VS 2026
1.3.2 Fungal Infection Therapy
1.3.3 Cancer & Tumor Therapy
1.3.4 Others
1.4 Global Liposomes Drug Delivery Market Size Estimates and Forecasts
1.4.1 Global Liposomes Drug Delivery Revenue 2015-2026
1.4.2 Global Liposomes Drug Delivery Sales 2015-2026
1.4.3 Liposomes Drug Delivery Market Size by Region: 2020 Versus 2026
2 Global Liposomes Drug Delivery Market Competition by Manufacturers
2.1 Global Liposomes Drug Delivery Sales Market Share by Manufacturers (2015-2020)
2.2 Global Liposomes Drug Delivery Revenue Share by Manufacturers (2015-2020)
2.3 Global Liposomes Drug Delivery Average Price by Manufacturers (2015-2020)
2.4 Manufacturers Liposomes Drug Delivery Manufacturing Sites, Area Served, Product Type
2.5 Liposomes Drug Delivery Market Competitive Situation and Trends
2.5.1 Liposomes Drug Delivery Market Concentration Rate
2.5.2 Global Top 5 and Top 10 Players Market Share by Revenue
2.5.3 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
2.7 Primary Interviews with Key Liposomes Drug Delivery Players (Opinion Leaders)
3 Liposomes Drug Delivery Retrospective Market Scenario by Region
3.1 Global Liposomes Drug Delivery Retrospective Market Scenario in Sales by Region: 2015-2020
3.2 Global Liposomes Drug Delivery Retrospective Market Scenario in Revenue by Region: 2015-2020
3.3 North America Liposomes Drug Delivery Market Facts & Figures by Country
3.3.1 North America Liposomes Drug Delivery Sales by Country
3.3.2 North America Liposomes Drug Delivery Sales by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Liposomes Drug Delivery Market Facts & Figures by Country
3.4.1 Europe Liposomes Drug Delivery Sales by Country
3.4.2 Europe Liposomes Drug Delivery Sales by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Liposomes Drug Delivery Market Facts & Figures by Region
3.5.1 Asia Pacific Liposomes Drug Delivery Sales by Region
3.5.2 Asia Pacific Liposomes Drug Delivery Sales by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Liposomes Drug Delivery Market Facts & Figures by Country
3.6.1 Latin America Liposomes Drug Delivery Sales by Country
3.6.2 Latin America Liposomes Drug Delivery Sales by Country
3.6.3 Mexico
3.6.3 Brazil
3.6.3 Argentina
3.7 Middle East and Africa Liposomes Drug Delivery Market Facts & Figures by Country
3.7.1 Middle East and Africa Liposomes Drug Delivery Sales by Country
3.7.2 Middle East and Africa Liposomes Drug Delivery Sales by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 Global Liposomes Drug Delivery Historic Market Analysis by Type
4.1 Global Liposomes Drug Delivery Sales Market Share by Type (2015-2020)
4.2 Global Liposomes Drug Delivery Revenue Market Share by Type (2015-2020)
4.3 Global Liposomes Drug Delivery Price Market Share by Type (2015-2020)
4.4 Global Liposomes Drug Delivery Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Global Liposomes Drug Delivery Historic Market Analysis by Application
5.1 Global Liposomes Drug Delivery Sales Market Share by Application (2015-2020)
5.2 Global Liposomes Drug Delivery Revenue Market Share by Application (2015-2020)
5.3 Global Liposomes Drug Delivery Price by Application (2015-2020)
6 Company Profiles and Key Figures in Liposomes Drug Delivery Business
6.1 Gilead Sciences
6.1.1 Corporation Information
6.1.2 Gilead Sciences Description, Business Overview and Total Revenue
6.1.3 Gilead Sciences Liposomes Drug Delivery Sales, Revenue and Gross Margin (2015-2020)
6.1.4 Gilead Sciences Products Offered
6.1.5 Gilead Sciences Recent Development
6.2 Pacira
6.2.1 Pacira Liposomes Drug Delivery Production Sites and Area Served
6.2.2 Pacira Description, Business Overview and Total Revenue
6.2.3 Pacira Liposomes Drug Delivery Sales, Revenue and Gross Margin (2015-2020)
6.2.4 Pacira Products Offered
6.2.5 Pacira Recent Development
6.3 Sun Pharmaceutical
6.3.1 Sun Pharmaceutical Liposomes Drug Delivery Production Sites and Area Served
6.3.2 Sun Pharmaceutical Description, Business Overview and Total Revenue
6.3.3 Sun Pharmaceutical Liposomes Drug Delivery Sales, Revenue and Gross Margin (2015-2020)
6.3.4 Sun Pharmaceutical Products Offered
6.3.5 Sun Pharmaceutical Recent Development
6.4 Johnson & Johnson
6.4.1 Johnson & Johnson Liposomes Drug Delivery Production Sites and Area Served
6.4.2 Johnson & Johnson Description, Business Overview and Total Revenue
6.4.3 Johnson & Johnson Liposomes Drug Delivery Sales, Revenue and Gross Margin (2015-2020)
6.4.4 Johnson & Johnson Products Offered
6.4.5 Johnson & Johnson Recent Development
6.5 Luye Pharma
6.5.1 Luye Pharma Liposomes Drug Delivery Production Sites and Area Served
6.5.2 Luye Pharma Description, Business Overview and Total Revenue
6.5.3 Luye Pharma Liposomes Drug Delivery Sales, Revenue and Gross Margin (2015-2020)
6.5.4 Luye Pharma Products Offered
6.5.5 Luye Pharma Recent Development
6.6 Sigma-Tau Group
6.6.1 Sigma-Tau Group Liposomes Drug Delivery Production Sites and Area Served
6.6.2 Sigma-Tau Group Description, Business Overview and Total Revenue
6.6.3 Sigma-Tau Group Liposomes Drug Delivery Sales, Revenue and Gross Margin (2015-2020)
6.6.4 Sigma-Tau Group Products Offered
6.6.5 Sigma-Tau Group Recent Development
6.7 Ipsen (Onivyde)
6.6.1 Ipsen (Onivyde) Liposomes Drug Delivery Production Sites and Area Served
6.6.2 Ipsen (Onivyde) Description, Business Overview and Total Revenue
6.6.3 Ipsen (Onivyde) Liposomes Drug Delivery Sales, Revenue and Gross Margin (2015-2020)
6.4.4 Ipsen (Onivyde) Products Offered
6.7.5 Ipsen (Onivyde) Recent Development
6.8 CSPC
6.8.1 CSPC Liposomes Drug Delivery Production Sites and Area Served
6.8.2 CSPC Description, Business Overview and Total Revenue
6.8.3 CSPC Liposomes Drug Delivery Sales, Revenue and Gross Margin (2015-2020)
6.8.4 CSPC Products Offered
6.8.5 CSPC Recent Development
6.9 Teva Pharmaceutical
6.9.1 Teva Pharmaceutical Liposomes Drug Delivery Production Sites and Area Served
6.9.2 Teva Pharmaceutical Description, Business Overview and Total Revenue
6.9.3 Teva Pharmaceutical Liposomes Drug Delivery Sales, Revenue and Gross Margin (2015-2020)
6.9.4 Teva Pharmaceutical Products Offered
6.9.5 Teva Pharmaceutical Recent Development
6.10 Novartis
6.10.1 Novartis Liposomes Drug Delivery Production Sites and Area Served
6.10.2 Novartis Description, Business Overview and Total Revenue
6.10.3 Novartis Liposomes Drug Delivery Sales, Revenue and Gross Margin (2015-2020)
6.10.4 Novartis Products Offered
6.10.5 Novartis Recent Development
6.11 Fudan-Zhangjiang
6.11.1 Fudan-Zhangjiang Liposomes Drug Delivery Production Sites and Area Served
6.11.2 Fudan-Zhangjiang Liposomes Drug Delivery Description, Business Overview and Total Revenue
6.11.3 Fudan-Zhangjiang Liposomes Drug Delivery Sales, Revenue and Gross Margin (2015-2020)
6.11.4 Fudan-Zhangjiang Products Offered
6.11.5 Fudan-Zhangjiang Recent Development
7 Liposomes Drug Delivery Manufacturing Cost Analysis
7.1 Liposomes Drug Delivery Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Raw Materials Price Trend
7.1.3 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Liposomes Drug Delivery
7.4 Liposomes Drug Delivery Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Liposomes Drug Delivery Distributors List
8.3 Liposomes Drug Delivery Customers
9 Market Dynamics
9.1 Market Trends
9.2 Opportunities and Drivers
9.3 Challenges
9.4 Porter's Five Forces Analysis
10 Global Market Forecast
10.1 Global Liposomes Drug Delivery Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Liposomes Drug Delivery by Type (2021-2026)
10.1.2 Global Forecasted Revenue of Liposomes Drug Delivery by Type (2021-2026)
10.2 Liposomes Drug Delivery Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Liposomes Drug Delivery by Application (2021-2026)
10.2.2 Global Forecasted Revenue of Liposomes Drug Delivery by Application (2021-2026)
10.3 Liposomes Drug Delivery Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Liposomes Drug Delivery by Region (2021-2026)
10.3.2 Global Forecasted Revenue of Liposomes Drug Delivery by Region (2021-2026)
10.4 North America Liposomes Drug Delivery Estimates and Projections (2021-2026)
10.5 Europe Liposomes Drug Delivery Estimates and Projections (2021-2026)
10.6 Asia Pacific Liposomes Drug Delivery Estimates and Projections (2021-2026)
10.7 Latin America Liposomes Drug Delivery Estimates and Projections (2021-2026)
10.8 Middle East and Africa Liposomes Drug Delivery Estimates and Projections (2021-2026)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of Tables
Table 1. Global Liposomes Drug Delivery Sales (K Vial) Growth Rate Comparison by Type (2015-2026)
Table 2. Global Liposomes Drug Delivery Sales (K Vial) Comparison by Application: 2020 VS 2026
Table 3. Global Liposomes Drug Delivery Market Size by Type (K Vial) (US$ Million) (2020 VS 2026)
Table 4. Global Key Liposomes Drug Delivery Manufacturers Covered in This Study
Table 5. Global Liposomes Drug Delivery Sales (K Vial) by Manufacturers (2015-2020)
Table 6. Global Liposomes Drug Delivery Sales Share by Manufacturers (2015-2020)
Table 7. Global Liposomes Drug Delivery Revenue (Million USD) by Manufacturers (2015-2020)
Table 8. Global Liposomes Drug Delivery Revenue Share by Manufacturers (2015-2020)
Table 9. Global Market Liposomes Drug Delivery Average Price (USD/Vial) of Key Manufacturers (2015-2020)
Table 10. Manufacturers Liposomes Drug Delivery Sales Sites and Area Served
Table 11. Manufacturers Liposomes Drug Delivery Product Types
Table 12. Global Liposomes Drug Delivery Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Liposomes Drug Delivery by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Liposomes Drug Delivery as of 2019)
Table 14.Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Main Points Interviewed from Key Liposomes Drug Delivery Players
Table 16. Global Liposomes Drug Delivery Sales (K Vial) by Region (2015-2020)
Table 17. Global Liposomes Drug Delivery Sales Market Share by Region (2015-2020)
Table 18. Global Liposomes Drug Delivery Revenue (Million US$) by Region (2015-2020)
Table 19. Global Liposomes Drug Delivery Revenue Market Share by Region (2015-2020)
Table 20. North America Liposomes Drug Delivery Sales by Country (2015-2020) (K Vial)
Table 21. North America Liposomes Drug Delivery Sales Market Share by Country (2015-2020)
Table 22. North America Liposomes Drug Delivery Revenue by Country (2015-2020) (US$ Million)
Table 23. North America Liposomes Drug Delivery Revenue Market Share by Country (2015-2020)
Table 24. Europe Liposomes Drug Delivery Sales by Country (2015-2020) (K Vial)
Table 25. Europe Liposomes Drug Delivery Sales Market Share by Country (2015-2020)
Table 26. Europe Liposomes Drug Delivery Revenue by Country (2015-2020) (US$ Million)
Table 27. Europe Liposomes Drug Delivery Revenue Market Share by Country (2015-2020)
Table 28. Asia Pacific Liposomes Drug Delivery Sales by Region (2015-2020) (K Vial)
Table 29. Asia Pacific Liposomes Drug Delivery Sales Market Share by Region (2015-2020)
Table 30. Asia Pacific Liposomes Drug Delivery Revenue by Region (2015-2020) (US$ Million)
Table 31. Asia Pacific Liposomes Drug Delivery Revenue Market Share by Region (2015-2020)
Table 32. Latin America Liposomes Drug Delivery Sales by Country (2015-2020) (K Vial)
Table 33. Latin America Liposomes Drug Delivery Sales Market Share by Country (2015-2020)
Table 34. Latin America Liposomes Drug Delivery Revenue by Country (2015-2020) (US$ Million)
Table 35. Latin America Liposomes Drug Delivery Revenue Market Share by Country (2015-2020)
Table 36. Middle East and Africa Liposomes Drug Delivery Sales by Country (2015-2020) (K Vial)
Table 37. Middle East and Africa Liposomes Drug Delivery Sales Market Share by Country (2015-2020)
Table 38. Middle East and Africa Liposomes Drug Delivery Revenue by Country (2015-2020) (US$ Million)
Table 39. Middle East and Africa Liposomes Drug Delivery Revenue Market Share by Country (2015-2020)
Table 40. Global Liposomes Drug Delivery Sales (K Vial) by Type (2015-2020)
Table 41. Global Liposomes Drug Delivery Sales Share by Type (2015-2020)
Table 42. Global Liposomes Drug Delivery Revenue (Million US$) by Type (2015-2020)
Table 43. Global Liposomes Drug Delivery Revenue Share by Type (2015-2020)
Table 44. Global Liposomes Drug Delivery Price (USD/Vial) by Type (2015-2020)
Table 45. Global Liposomes Drug Delivery Sales (K Vial) by Application (2015-2020)
Table 46. Global Liposomes Drug Delivery Sales Market Share by Application (2015-2020)
Table 47. Global Liposomes Drug Delivery Sales Growth Rate by Application (2015-2020)
Table 48. Gilead Sciences Liposomes Drug Delivery Corporation Information
Table 49. Gilead Sciences Description and Business Overview
Table 50. Gilead Sciences Liposomes Drug Delivery Sales (K Vial), Revenue (Million US$), Price (USD/Vial) and Gross Margin (2015-2020)
Table 51. Gilead Sciences Main Product
Table 52. Gilead Sciences Recent Development
Table 53. Pacira Liposomes Drug Delivery Corporation Information
Table 54. Pacira Corporation Information
Table 55. Pacira Liposomes Drug Delivery Sales (K Vial), Revenue (Million US$), Price (USD/Vial) and Gross Margin (2015-2020)
Table 56. Pacira Main Product
Table 57. Pacira Recent Development
Table 58. Sun Pharmaceutical Liposomes Drug Delivery Corporation Information
Table 59. Sun Pharmaceutical Corporation Information
Table 60. Sun Pharmaceutical Liposomes Drug Delivery Sales (K Vial), Revenue (Million US$), Price (USD/Vial) and Gross Margin (2015-2020)
Table 61. Sun Pharmaceutical Main Product
Table 62. Sun Pharmaceutical Recent Development
Table 63. Johnson & Johnson Liposomes Drug Delivery Corporation Information
Table 64. Johnson & Johnson Corporation Information
Table 65. Johnson & Johnson Liposomes Drug Delivery Sales (K Vial), Revenue (Million US$), Price (USD/Vial) and Gross Margin (2015-2020)
Table 66. Johnson & Johnson Main Product
Table 67. Johnson & Johnson Recent Development
Table 68. Luye Pharma Liposomes Drug Delivery Corporation Information
Table 69. Luye Pharma Corporation Information
Table 70. Luye Pharma Liposomes Drug Delivery Sales (K Vial), Revenue (Million US$), Price (USD/Vial) and Gross Margin (2015-2020)
Table 71. Luye Pharma Main Product
Table 72. Luye Pharma Recent Development
Table 73. Sigma-Tau Group Liposomes Drug Delivery Corporation Information
Table 74. Sigma-Tau Group Corporation Information
Table 75. Sigma-Tau Group Liposomes Drug Delivery Sales (K Vial), Revenue (Million US$), Price (USD/Vial) and Gross Margin (2015-2020)
Table 76. Sigma-Tau Group Main Product
Table 77. Sigma-Tau Group Recent Development
Table 78. Ipsen (Onivyde) Liposomes Drug Delivery Corporation Information
Table 79. Ipsen (Onivyde) Corporation Information
Table 80. Ipsen (Onivyde) Liposomes Drug Delivery Sales (K Vial), Revenue (Million US$), Price (USD/Vial) and Gross Margin (2015-2020)
Table 81. Ipsen (Onivyde) Main Product
Table 82. Ipsen (Onivyde) Recent Development
Table 83. CSPC Liposomes Drug Delivery Corporation Information
Table 84. CSPC Corporation Information
Table 85. CSPC Liposomes Drug Delivery Sales (K Vial), Revenue (Million US$), Price (USD/Vial) and Gross Margin (2015-2020)
Table 86. CSPC Main Product
Table 87. CSPC Recent Development
Table 88. Teva Pharmaceutical Liposomes Drug Delivery Corporation Information
Table 89. Teva Pharmaceutical Corporation Information
Table 90. Teva Pharmaceutical Liposomes Drug Delivery Sales (K Vial), Revenue (Million US$), Price (USD/Vial) and Gross Margin (2015-2020)
Table 91. Teva Pharmaceutical Main Product
Table 92. Teva Pharmaceutical Recent Development
Table 93. Novartis Liposomes Drug Delivery Corporation Information
Table 94. Novartis Corporation Information
Table 95. Novartis Liposomes Drug Delivery Sales (K Vial), Revenue (Million US$), Price (USD/Vial) and Gross Margin (2015-2020)
Table 96. Novartis Main Product
Table 97. Novartis Recent Development
Table 98. Fudan-Zhangjiang Liposomes Drug Delivery Corporation Information
Table 99. Fudan-Zhangjiang Corporation Information
Table 100. Fudan-Zhangjiang Liposomes Drug Delivery Sales (K Vial), Revenue (Million US$), Price (USD/Vial) and Gross Margin (2015-2020)
Table 101. Fudan-Zhangjiang Main Product
Table 102. Fudan-Zhangjiang Recent Development
Table 103. Sales Base and Market Concentration Rate of Raw Material
Table 104. Key Suppliers of Raw Materials
Table 105. Liposomes Drug Delivery Distributors List
Table 106. Liposomes Drug Delivery Customers List
Table 107. Market Key Trends
Table 108. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 109. Key Challenges
Table 110. Global Liposomes Drug Delivery Sales (K Vial) Forecast by Type (2021-2026)
Table 111. Global Liposomes Drug Delivery Sales Market Share Forecast by Type (2021-2026)
Table 112. Global Liposomes Drug Delivery Revenue (Million US$) Forecast by Type (2021-2026)
Table 113. Global Liposomes Drug Delivery Revenue (Million US$) Market Share Forecast by Type (2021-2026)
Table 114. Global Liposomes Drug Delivery Sales (K Vial) Forecast by Application (2021-2026)
Table 115. Global Liposomes Drug Delivery Revenue (Million US$) Forecast by Application (2021-2026)
Table 116. Global Liposomes Drug Delivery Sales (K Vial) Forecast by Region (2021-2026)
Table 117. Global Liposomes Drug Delivery Sales Market Share Forecast by Region (2021-2026)
Table 118. Global Liposomes Drug Delivery Revenue Forecast by Region (2021-2026) (US$ Million)
Table 119. Global Liposomes Drug Delivery Revenue Market Share Forecast by Region (2021-2026)
Table 120. Research Programs/Design for This Report
Table 121. Key Data Information from Secondary Sources
Table 122. Key Data Information from Primary Sources
List of Figures
Figure 1. Picture of Liposomes Drug Delivery
Figure 2. Global Liposomes Drug Delivery Sales Market Share by Type: 2020 VS 2026
Figure 3. Liposomal Doxorubicin Product Picture
Figure 4. Liposomal Amphoteracin B Product Picture
Figure 5. Liposomal Paclitaxel Product Picture
Figure 6. Others Product Picture
Figure 7. Global Liposomes Drug Delivery Consumption Market Share by Application: 2020 VS 2026
Figure 8. Fungal Infection Therapy
Figure 9. Cancer & Tumor Therapy
Figure 10. Others
Figure 11. Global Liposomes Drug Delivery Market Size 2015-2026 (US$ Million)
Figure 12. Global Liposomes Drug Delivery Sales Capacity (K Vial) (2015-2026)
Figure 13. Global Liposomes Drug Delivery Market Size Market Share by Region: 2020 Versus 2026
Figure 14. Liposomes Drug Delivery Sales Share by Manufacturers in 2020
Figure 15. Global Liposomes Drug Delivery Revenue Share by Manufacturers in 2019
Figure 16. The Global 5 and 10 Largest Players: Market Share by Liposomes Drug Delivery Revenue in 2019
Figure 17. Liposomes Drug Delivery Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 18. Global Liposomes Drug Delivery Sales Market Share by Region (2015-2020)
Figure 19. Global Liposomes Drug Delivery Sales Market Share by Region in 2019
Figure 20. Global Liposomes Drug Delivery Revenue Market Share by Region (2015-2020)
Figure 21. Global Liposomes Drug Delivery Revenue Market Share by Region in 2019
Figure 22. North America Liposomes Drug Delivery Sales Market Share by Country in 2019
Figure 23. North America Liposomes Drug Delivery Revenue Market Share by Country in 2019
Figure 24. U.S. Liposomes Drug Delivery Sales Growth Rate (2015-2020) (K Vial)
Figure 25. U.S. Liposomes Drug Delivery Revenue Growth Rate (2015-2020) (US$ Million)
Figure 26. Canada Liposomes Drug Delivery Sales Growth Rate (2015-2020) (K Vial)
Figure 27. Canada Liposomes Drug Delivery Revenue Growth Rate (2015-2020) (US$ Million)
Figure 28. Europe Liposomes Drug Delivery Sales Market Share by Country in 2019
Figure 29. Europe Liposomes Drug Delivery Revenue Market Share by Country in 2019
Figure 30. Germany Liposomes Drug Delivery Sales Growth Rate (2015-2020) (K Vial)
Figure 31. Germany Liposomes Drug Delivery Revenue Growth Rate (2015-2020) (US$ Million)
Figure 32. France Liposomes Drug Delivery Sales Growth Rate (2015-2020) (K Vial)
Figure 33. France Liposomes Drug Delivery Revenue Growth Rate (2015-2020) (US$ Million)
Figure 34. U.K. Liposomes Drug Delivery Sales Growth Rate (2015-2020) (K Vial)
Figure 35. U.K. Liposomes Drug Delivery Revenue Growth Rate (2015-2020) (US$ Million)
Figure 36. Italy Liposomes Drug Delivery Sales Growth Rate (2015-2020) (K Vial)
Figure 37. Italy Liposomes Drug Delivery Revenue Growth Rate (2015-2020) (US$ Million)
Figure 38. Russia Liposomes Drug Delivery Sales Growth Rate (2015-2020) (K Vial)
Figure 39. Russia Liposomes Drug Delivery Revenue Growth Rate (2015-2020) (US$ Million)
Figure 40. Asia Pacific Liposomes Drug Delivery Sales Market Share by Region in 2019
Figure 41. Asia Pacific Liposomes Drug Delivery Revenue Market Share by Region in 2019
Figure 42. China Liposomes Drug Delivery Sales Growth Rate (2015-2020) (K Vial)
Figure 43. China Liposomes Drug Delivery Revenue Growth Rate (2015-2020) (US$ Million)
Figure 44. Japan Liposomes Drug Delivery Sales Growth Rate (2015-2020) (K Vial)
Figure 45. Japan Liposomes Drug Delivery Revenue Growth Rate (2015-2020) (US$ Million)
Figure 46. South Korea Liposomes Drug Delivery Sales Growth Rate (2015-2020) (K Vial)
Figure 47. South Korea Liposomes Drug Delivery Revenue Growth Rate (2015-2020) (US$ Million)
Figure 48. India Liposomes Drug Delivery Sales Growth Rate (2015-2020) (K Vial)
Figure 49. India Liposomes Drug Delivery Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. Australia Liposomes Drug Delivery Sales Growth Rate (2015-2020) (K Vial)
Figure 51. Australia Liposomes Drug Delivery Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. Taiwan Liposomes Drug Delivery Sales Growth Rate (2015-2020) (K Vial)
Figure 53. Taiwan Liposomes Drug Delivery Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. Indonesia Liposomes Drug Delivery Sales Growth Rate (2015-2020) (K Vial)
Figure 55. Indonesia Liposomes Drug Delivery Revenue Growth Rate (2015-2020) (US$ Million)
Figure 56. Thailand Liposomes Drug Delivery Sales Growth Rate (2015-2020) (K Vial)
Figure 57. Thailand Liposomes Drug Delivery Revenue Growth Rate (2015-2020) (US$ Million)
Figure 58. Malaysia Liposomes Drug Delivery Sales Growth Rate (2015-2020) (K Vial)
Figure 59. Malaysia Liposomes Drug Delivery Revenue Growth Rate (2015-2020) (US$ Million)
Figure 60. Philippines Liposomes Drug Delivery Sales Growth Rate (2015-2020) (K Vial)
Figure 61. Philippines Liposomes Drug Delivery Revenue Growth Rate (2015-2020) (US$ Million)
Figure 62. Vietnam Liposomes Drug Delivery Sales Growth Rate (2015-2020) (K Vial)
Figure 63. Vietnam Liposomes Drug Delivery Revenue Growth Rate (2015-2020) (US$ Million)
Figure 64. Latin America Liposomes Drug Delivery Sales Market Share by Country in 2019
Figure 65. Latin America Liposomes Drug Delivery Revenue Market Share by Country in 2019
Figure 66. Mexico Liposomes Drug Delivery Sales Growth Rate (2015-2020) (K Vial)
Figure 67. Mexico Liposomes Drug Delivery Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. Brazil Liposomes Drug Delivery Sales Growth Rate (2015-2020) (K Vial)
Figure 69. Brazil Liposomes Drug Delivery Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. Argentina Liposomes Drug Delivery Sales Growth Rate (2015-2020) (K Vial)
Figure 71. Argentina Liposomes Drug Delivery Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Middle East and Africa Liposomes Drug Delivery Sales Market Share by Country in 2019
Figure 73. Middle East and Africa Liposomes Drug Delivery Revenue Market Share by Country in 2019
Figure 74. Turkey Liposomes Drug Delivery Sales Growth Rate (2015-2020) (K Vial)
Figure 75. Turkey Liposomes Drug Delivery Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Saudi Arabia Liposomes Drug Delivery Sales Growth Rate (2015-2020) (K Vial)
Figure 77. Saudi Arabia Liposomes Drug Delivery Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. U.A.E Liposomes Drug Delivery Sales Growth Rate (2015-2020) (K Vial)
Figure 79. U.A.E Liposomes Drug Delivery Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Sales Market Share of Liposomes Drug Delivery by Type (2015-2020)
Figure 81. Sales Market Share of Liposomes Drug Delivery by Type in 2019
Figure 82. Revenue Share of Liposomes Drug Delivery by Type (2015-2020)
Figure 83. Revenue Market Share of Liposomes Drug Delivery by Type in 2019
Figure 84. Global Liposomes Drug Delivery Sales Growth by Type (2015-2020) (K Vial)
Figure 85. Global Liposomes Drug Delivery Sales Market Share by Application (2015-2020)
Figure 86. Global Liposomes Drug Delivery Sales Market Share by Application in 2019
Figure 87. Global Revenue Share of Liposomes Drug Delivery by Application (2015-2020)
Figure 88. Global Revenue Share of Liposomes Drug Delivery by Application in 2020
Figure 89. Gilead Sciences Total Revenue (US$ Million): 2019 Compared with 2018
Figure 90. Pacira Total Revenue (US$ Million): 2019 Compared with 2018
Figure 91. Sun Pharmaceutical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 92. Johnson & Johnson Total Revenue (US$ Million): 2019 Compared with 2018
Figure 93. Luye Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 94. Sigma-Tau Group Total Revenue (US$ Million): 2019 Compared with 2018
Figure 95. Ipsen (Onivyde) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 96. CSPC Total Revenue (US$ Million): 2019 Compared with 2018
Figure 97. Teva Pharmaceutical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 98. Novartis Total Revenue (US$ Million): 2019 Compared with 2018
Figure 99. Fudan-Zhangjiang Total Revenue (US$ Million): 2019 Compared with 2018
Figure 100. Price Trend of Key Raw Materials
Figure 101. Manufacturing Cost Structure of Liposomes Drug Delivery
Figure 102. Manufacturing Process Analysis of Liposomes Drug Delivery
Figure 103. Liposomes Drug Delivery Industrial Chain Analysis
Figure 104. Channels of Distribution
Figure 105. Distributors Profiles
Figure 106. Porter's Five Forces Analysis
Figure 107. North America Liposomes Drug Delivery Sales (K Vial) and Growth Rate Forecast (2021-2026)
Figure 108. North America Liposomes Drug Delivery Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 109. Europe Liposomes Drug Delivery Sales (K Vial) and Growth Rate Forecast (2021-2026)
Figure 110. Europe Liposomes Drug Delivery Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 111. Latin America Liposomes Drug Delivery Sales (K Vial) and Growth Rate Forecast (2021-2026)
Figure 112. Latin America Liposomes Drug Delivery Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 113. Middle East and Africa Liposomes Drug Delivery Sales (K Vial) and Growth Rate Forecast (2021-2026)
Figure 114. Middle East and Africa Liposomes Drug Delivery Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 115. Asia Pacific Liposomes Drug Delivery Sales (K Vial) and Growth Rate Forecast (2021-2026)
Figure 116. Asia Pacific Liposomes Drug Delivery Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 117. Bottom-up and Top-down Approaches for This Report
Figure 118. Data Triangulation
Figure 119. Key Executives Interviewed

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Gold Nanoparticles Market Research Report 2024

Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 121

Gold nanoparticles are particles with diameters in The 1-100nm range and have unique optical and physical properties. These unique optical-electronics properties have been researched and utilized in high technology applications such as organic photovoltaics, sensory probes, therapeutic agents, drug delivery in biological and medical applications, electronic conductors and catalysis. The optical and electronic properties of gold nanoparticles are tunable by changing The size, shape, surface chemi......

Global High Volume Subcutaneous Drug Delivery Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 04-Jan-2024        Price: US 3380 Onwards        Pages: 109

Market Overview of Global High Volume Subcutaneous Drug Delivery market: According to our latest research, the global High Volume Subcutaneous Drug Delivery market looks promising in the next 5 years. As of 2022, the global High Volume Subcutaneous Drug Delivery market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a dee......

Global Gold Nanoparticles Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 134

According to our LPI (LP Information) latest study, the global Gold Nanoparticles market size was valued at US$ 86 million in 2023. With growing demand in downstream market, the Gold Nanoparticles is forecast to a readjusted size of US$ 200.8 million by 2030 with a CAGR of 12.9% during review period. The research report highlights the growth potential of the global Gold Nanoparticles market. Gold Nanoparticles are expected to show stable growth in the future market. However, product diff......

Global Liposome Drug Delivery Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 123

According to our LPI (LP Information) latest study, the global Liposome Drug Delivery market size was valued at US$ 3652.8 million in 2023. With growing demand in downstream market, the Liposome Drug Delivery is forecast to a readjusted size of US$ 8742.8 million by 2030 with a CAGR of 13.3% during review period. The research report highlights the growth potential of the global Liposome Drug Delivery market. Liposome Drug Delivery are expected to show stable growth in the future market. ......

Global Transdermal Drug Delivery System Market Growth (Status and Outlook) 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 127

According to our LPI (LP Information) latest study, the global Transdermal Drug Delivery System market size was valued at US$ 14730 million in 2023. With growing demand in downstream market, the Transdermal Drug Delivery System is forecast to a readjusted size of US$ 36410 million by 2030 with a CAGR of 13.8% during review period. The research report highlights the growth potential of the global Transdermal Drug Delivery System market. Transdermal Drug Delivery System are expected to sho......

Global Liposomes Drug Delivery Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 117

According to our LPI (LP Information) latest study, the global Liposomes Drug Delivery market size was valued at US$ 3262.7 million in 2023. With growing demand in downstream market, the Liposomes Drug Delivery is forecast to a readjusted size of US$ 6510.7 million by 2030 with a CAGR of 10.4% during review period. The research report highlights the growth potential of the global Liposomes Drug Delivery market. Liposomes Drug Delivery are expected to show stable growth in the future mark......

Global Gold Nanoparticles Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Published: 01-Jan-2024        Price: US 3480 Onwards        Pages: 129

According to our (Global Info Research) latest study, the global Gold Nanoparticles market size was valued at USD 91 million in 2023 and is forecast to a readjusted size of USD 198.5 million by 2030 with a CAGR of 11.9% during review period. Gold nanoparticles are particles with diameters in the 1-100nm range and have unique optical and physical properties. These unique optical-electronics properties have been researched and utilized in high technology applications such as organic photov......

Global Polymers Drug Delivery Market Research Report 2023, Forecast to 2028

Published: 27-Dec-2023        Price: US 2680 Onwards        Pages: 160

Polymeric drug delivery system has defined as a formulation or a device that enables the introduction of a therapeutic substance into the body. It improves its safety and efficacy by controlling the rate, time, and place of release of drugs in the body. Polymeric drug delivery system has defined as a formulation or a device that enables the introduction of a therapeutic substance into the body. It improves its safety and efficacy by controlling the rate, time, and place of release of drug......

Global Polymers Drug Delivery Professional Survey Report 2023, Forecast to 2028

Published: 27-Dec-2023        Price: US 3280 Onwards        Pages: 135

Polymeric drug delivery system has defined as a formulation or a device that enables the introduction of a therapeutic substance into the body. It improves its safety and efficacy by controlling the rate, time, and place of release of drugs in the body. Polymeric drug delivery system has defined as a formulation or a device that enables the introduction of a therapeutic substance into the body. It improves its safety and efficacy by controlling the rate, time, and place of release of drug......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs